MG

Marie-Lise Gougeon

IP Institut Pasteur: 14 patents #35 of 1,210Top 3%
A( Assistance Publique—Hôpitaux De Paris (Aphp): 4 patents #40 of 877Top 5%
U7 Université Paris Diderot—Paris 7: 2 patents #26 of 323Top 9%
UP Université Paris-Sud: 2 patents #30 of 307Top 10%
UD Universite De Paris Descartes: 1 patents #86 of 364Top 25%
UC Université Pierre Et Marie Curie: 1 patents #47 of 215Top 25%
IR Institut Gustave Roussy: 1 patents #73 of 201Top 40%
Overall (All Time): #339,970 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12105095 Assay to detect and quantitate specific antibodies for various redox forms of HMGB1 Nicole Prada, Hela Saidi 2024-10-01
11460473 Assay to detect and quantitate specific an antibodies for various redox forms of HMGB1 Nicole Prada, Hela Saidi 2022-10-04
10890583 Predictive value of Clostridium difficile-specific immune response for recurrence and disease outcome Alban Le Monnier, Anne Collignon, Michel-Robert Popoff 2021-01-12
10018629 Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus Manuelle Viguier, Hervé Bachelez, Nicolas Fazilleau 2018-07-10
10012655 Method for quantitating total HMGB1 protein in biological samples Hela Saidi, Marie-Therese Melki, Beatrice Poirier-Beaudoin, Valerie Seffer 2018-07-03
9938528 Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections Guido Kroemer, Jean-Luc PERFETTINI, Awatef ALLOUCH, Mauro Piacentini 2018-04-10
9766254 HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders Beatrice Poirier-Beaudoin, Valerie Seffer, Hela Saidi 2017-09-19
9547006 Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus Manuelle Viguier, Hervé Bachelez, Nicolas Fazilleau 2017-01-17
9164103 Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence Hela Saidi, Marie-Therese Melki, Beatrice Poirier-Beaudoin, Valerie Seffer 2015-10-20
9164107 HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders Beatrice Poirier-Beaudoin, Valerie Seffer, Hela Saidi 2015-10-20
8906634 Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence Hela Saidi, Marie-Therese Melki, Beatrice Poirier-Beaudoin, Valerie Seffer 2014-12-09
8728748 HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders Beatrice Poirier-Beaudoin, Valerie Seffer, Hela Saidi 2014-05-20
8603766 Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence Hela Saidi, Maria-Therese Melki, Beatrice Poirier-Beaudoin, Valerie Seffer 2013-12-10
8450076 Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence Hela Saidi, Maria-Therese Melki, Beatrice Poirier-Beaudoin, Valerie Seffer 2013-05-28